IDP DISCOVERY PHARMA S L has a total of 33 patent applications. It increased the IP activity by 316.0%. Its first patent ever was published in 2017. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are KINETA CHRONIC PAIN LLC, RADIMMUNE THERAPEUTICS INC and DENNIS MARK S.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | Australia | 5 | |
#3 | Canada | 5 | |
#4 | EPO (European Patent Office) | 5 | |
#5 | China | 4 | |
#6 | Republic of Korea | 4 | |
#7 | United States | 4 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Specific use of cosmetics |
# | Name | Total Patents |
---|---|---|
#1 | Nevola Laura | 33 |
#2 | Esteban Martín Santiago | 20 |
#3 | Esteban Martin Santiago | 13 |
#4 | Moreno Moreno Haritz | 6 |
#5 | Garayoa Mercedes | 6 |
#6 | Lecanda Cordero Fernando | 6 |
#7 | Krzeminski Patryk | 6 |
#8 | Ocio San Miguel Enrique Maria | 3 |
#9 | Ocio San Miguel Enrique María | 3 |
Publication | Filing date | Title |
---|---|---|
WO2021023646A1 | Melanocyte-regulating peptides | |
CN111405903A | Novel treatment for multiple myeloma | |
KR20200033936A | Anticancer peptide | |
CN111436200A | Anticancer peptides | |
CA3070874A1 | Anticancer peptides | |
WO2017157990A1 | Peptides with anti-cancer activity |